Home » drug metabolism

drug metabolism

Nov 28, 2017

Bio.logis Readies New Clinical Genetic Data Interpretation Tools Amid Growing Customer Interest

Premium

The firm will launch two new analysis modules for its Genetic Information Management Suite next year, in addition to a new pharmacogenomics mobile application.

Sep 26, 2017

Genotyping Appears to Offer Warfarin Dosing Edge in New Clinical Trial

Results from a randomized clinical trial known as GIFT suggest that genotype-guided warfarin dosing is linked to fewer adverse events than clinical dosing.

Aug 30, 2017

Common Variant Implicated in Statin-Related Muscle Aches

Data from several large cohorts suggests that a variant in LILRB5 may produce a propensity for muscle pain or myalgia, upping the risk of statin intolerance.

Jul 12, 2017

Estonian Team Pairs Pharmacogenomics, EHRs to Reduce Adverse Drug Reactions

Premium

The effort is already bearing fruit, as the team has been able to validate several variants known to be connected with adverse drug reactions.

May 03, 2017

This Week in Cell

In Cell this week: host-microbe interactions and cancer drug response; links between transcription rate, mRNA translation, and methylation; and more.

Nov 20, 2013

In Prescribing Study, Few Doctors Altered Treatment for Poor Plavix Metabolizers Based on Genotype

Premium

A study led by researchers from Brigham and Women's Hospital on the effect of CYP2C19 testing on physicians' prescribing patterns has found that when doctors received patient test results for genetic markers associated with clopidogrel response through a pharmacy-benefit manager-

Oct 23, 2013

Genewiz to Launch Clinical Versions of PGx and Cancer Panels Starting This Year

Premium

Genewiz, a contract research organization specializing in sequencing and other genomic services, has announced that it is branching out into the clinical sequencing and personalized medicine space with two sequencing panels — a 25-gene general pharmacogenomic panel and a 35-gene

Sep 24, 2013

Luminex CYP2C19 Assay Cleared by FDA, CE Marked in Europe

NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that its xTAG CYP2C19 kit has been cleared for marketing by the US Food and Drug Administration and has received the CE Mark in Europe.

Aug 27, 2013

UPDATE: Spartan Bioscience Gets FDA OK for Rapid CYP2C19 Assay

This article has been updated to clarify that the test has not been cleared for use in a point-of-care setting.

Jul 15, 2013

Luminex Gets FDA OK for New Version of CYP2D6 Kit

NEW YORK (GenomeWeb News) – Luminex announced after the close of the market Monday that the US Food and Drug Administration has cleared for marketing a new version of its xTAG CYP2D6 kit.

Pages

The Scan

Years and Years

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Diving Evolution

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

This Week in Science

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

Issues to Overcome

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Sponsorships

Privacy Policy.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.